NCT05888636View on ClinicalTrials.gov

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

November 11, 2023

Study Completion Date

December 31, 2024

Conditions
Multiple Myeloma
Interventions
OTHER

ChIP-seq, NGS, ATAC-seq

Bone narrow sampling

Trial Locations (2)

00144

ACTIVE_NOT_RECRUITING

Regina elena Cancer Institute, Roma

RECRUITING

"Regina Elena National Cancer Institute", Rome

All Listed Sponsors
collaborator

Campus Bio-Medico University

OTHER

collaborator

University of Rome Tor Vergata

OTHER

collaborator

Sant'Eugenio Hospital, Rome

UNKNOWN

lead

Regina Elena Cancer Institute

OTHER